Basal cells are located at the base of the epithelium and count for one-third of all cells (Travaglini and Krasnow, 2018; Deprez et al., 2020; Goldfarbmuren et al., 2020). These are progenitor cells that give rise to Club cells and to the rarer cell types (Montoro et al., 2018; Travaglini and Krasnow, 2018). Marker genes (summarized in Table 1) associated to basal cells are keratin 5 (KRT5) and tumor protein 63 (TP63), but these cells can be grouped in 3 cell populations which are distinguished by the expression of genes involved respectively in proliferation, differentiation and squamous metaplastic response to injury or stress (Deprez et al., 2020; Goldfarbmuren et al., 2020). Proliferating basal cells are enriched in the expression of genes involved in the cell cycle, indicating a proliferative state. Differentiating basal cells have a reduced expression of KRT5 and increased expression of Hes Family BHLH Transcription Factor 1 (HES1), keratin 7 (KRT7) and Secretoglobin Family 3A Member 2 (SCGB3A2), indicating active differentiation to other epithelial fates (Travaglini et al., 2020). Examples of genes involved in the response to injury or stress are keratin 14 (KRT14) and keratin 13 (KRT13) (Goldfarbmuren et al., 2020). CFTR expression is low in basal cells (Montoro et al., 2018), but overall, they are the second major contributor to CFTR mRNA content in the airway epithelium (Okuda et al., 2021) (Figure 1B).

Ciliated cells are the most abundant airway epithelial cells in the proximal airways and have been reported as significantly decreased in CF compared with control samples (Montoro et al., 2018; Scudieri et al., 2020). Fully differentiated ciliated cells express high levels of Forkhead Box J1 (FOXJ1), a transcription factor involved in ciliogenesis and ciliary maintenance (Deprez et al., 2020; Goldfarbmuren et al., 2020). Other ciliated cells markers are Tubulin Polymerization Promoting Protein Family Member 3 (TPPP3), and Sentan (SNTN). Deuterosomal cells, the precursors of ciliated cells, express the specific markers Deuterosome Assembly Protein 1 (DEUP1), Forkhead Box N4 (FOXN4), and Cell Division Cycle 20B (CDC20B). These cells carry protruding structures called cilia that swirl to clear mucus and debris (Travaglini and Krasnow, 2018). Even though ciliated cells have been hypothesized to be the major source of CFTR in the proximal airway and the vastly more abundant cells, they only express 1.5% of total CFTR (Montoro et al., 2018; Plasschaert et al., 2018), positioning them among the smallest contributors to total CFTR content in the airway epithelia (Okuda et al., 2021) (Figure 1B). This apparent contradiction was clarified by a recent report showing that the strong immunofluorescence staining observed of CFTR in ciliated cells is possibly due to cross detection of the protein rootletin located at the bases of motile cilia (Sato et al., 2021).

Club and goblet cells are both known as “secretory cells” as these 2 cell populations cluster together differing only by the levels of expression of mucin genes MUC5AC and MUC5B (Deprez et al., 2020). In fact, Club cells are known to be the precursors of Goblet and ciliated cells (Montoro et al., 2018). The Nuclear Factor I A (NFIA) is a transcription factor reported as enriched in Club cells (Montoro et al., 2018). This factor regulates Notch signaling, which is required for Club cell maintenance. Other markers enriched in secretory cells vary according to the maturity levels. The least-mature cells express basal cell transcripts such as KRT5 and TP63 while the most-mature cells express MUC5B (Plasschaert et al., 2018).

Secretory, as well as ciliated cells, are the 2 cell types responsible to removing inhaled particles from the upper airways (Travaglini and Krasnow, 2018; Deprez et al., 2020; Goldfarbmuren et al., 2020). Secretory cells secrete the components of the mucus, including mucins, antimicrobial and immune modulatory proteins, impeding particles from reaching deeper lung zones. Secretory cells regulate the composition of the airway surface liquid (ASL) covering the epithelium, without ASL the ciliary beating and mucociliary clearance would be compromised (Sato et al., 2023). Although CFTR levels in secretory cells are low (Montoro et al., 2018), secretory cells are the most common CFTR-expressing cells and thus they give the major contribution to total CFTR content in the airway epithelia—with a prominent role for the subtype Secretory 1 cells (Okuda et al., 2021) (Figure 1B). As secretory cells cover a large fraction of the airway surface, expression of CFTR in these cells has an important role in local control of airway surface hydration, which is in turn essential for mucus clearance.

Several studies identify low abundance clusters expressing markers enriched in Tuft cells, pulmonary neuroendocrine and ionocytes, which correspond to less than 1% of all epithelial cells (Deprez et al., 2020; Goldfarbmuren et al., 2020).

CFTR biogenesis occurs through the secretory pathway—the common route through which proteins synthesized in ribosomes attached to the endoplasmic reticulum (ER) are exported to the Golgi and subsequently to their target destination in the cell, which can be the lysosomes, extracellular medium or the PM as is the case for CFTR.

As it starts emerging from ribosome, CFTR is co-translationally inserted into the ER membrane (Lu et al., 1998), due to the presence of a signal sequence of around 7–25 mainly apolar amino acid residues (von Heijne, 1985). The signal recognition particle (SRP) recognizes and binds this sequence, directing the polypeptide and the attached ribosome to the ER membrane where it binds the SRP receptor. Then, the ribosome is anchored to the translocon channel, and, after release of the SRP and the SRP receptor, the signal sequence enters this channel leading to the co-translational transfer of the polypeptide chain into the ER membrane. Simultaneously to its ER membrane insertion, the nascent CFTR undergoes glycosylation in two asparagine residues of the fourth extracellular loop. An oligosaccharide with 14 residues (containing two N-acetylglucosamine, three glucose and nine mannose residues), which is synthesized in the ER, is transferred to each asparagine residue (Enquist et al., 2009) as they are located within the N-linked glycosylation consensus sequence Asn-X-Ser/Thr (Pless and Lennarz, 1977). This glycosylation event in the ER is catalyzed by a specific oligosaccharyltransferase and it originates a core-glycosylated or immature form of the CFTR protein, also known as band B CFTR, being band A CFTR the non-glycosylated form of the protein—that can only be detected after treating CFTR with a glycosidase that trims glycans (Cheng et al., 1990). Core-glycosylated CFTR has a fast turnover rate, with a half-life of around 30 min (Lukacs et al., 1994). Additionally, the modification of immature CFTR to the mature form following the secretory pathway is not a fully efficient process (Lukacs et al., 1994). Only around 20%–40% of the newly synthesized CFTR protein acquires the native conformation (Ward and Kopito, 1994), while the remaining is rapidly degraded before exiting the ER, meaning that CFTR folding and processing is less efficient in comparison to other ABC transporter proteins (Chang et al., 1997). Nevertheless, this is dependent on cell type, as it has been reported that CFTR processing is much more efficient in human epithelial cells (Varga et al., 2004).

CFTR undergoes a stringent ER quality control system (ERQC) with at least four checkpoints, which are responsible for recognizing non-native or abnormal membrane and secretory proteins and rapidly targeting them for degradation via the ubiquitin-proteasome pathway (Farinha and Amaral, 2005; Farinha et al., 2013; Canato et al., 2018). Within the ERQC machinery, molecular chaperones play a central role by facilitating correct protein folding in vivo through controlled binding and release of their substrate or, when this is not achieved, retaining misfolded proteins or unassembled subunits (Ohtsuka and Hata, 2000). Thus, chaperones are essential in facilitating domain assembly of CFTR and also in controlling how the glycosylation state affects CFTR trafficking.

The first checkpoint of the ERQC system occurs while the emerging CFTR polypeptide chain is being inserted into the ER membrane. During this, the exposed chain in the cytosol interacts with the cytosolic molecular chaperone Hsp70 and its co-chaperone Hdj-2 which facilitate the early steps of CFTR domain assembly and folding (Meacham, 1999; Farinha et al., 2002) and also regulate its early targeting to degradation (Kim Chiaw et al., 2019). Co-expression of Hsp70 and Hdj-1 stabilize the immature form of wt-CFTR but not of p.Phe508del-CFTR, suggesting that the amount of these molecular chaperones is not a limiting step for CFTR exit from the ER (Farinha et al., 2002). For mutant p.Phe508del-CFTR, it appears to become trapped in a stronger interaction with the chaperone Hsp90 and its co-chaperone Aha1, suggesting a relevant role of this complex in its retention in the ER (Hutt et al., 2012). If CFTR is retained too long in this chaperone trap it is targeted for degradation by replacement of the productive co-chaperones with pro-degradative ones. Chaperone mediated delivery to degradation systems has been suggested to play a role in the response of CFTR variants to modulators, with more responsive mutations exhibiting decreased interactions with the proteasomal and autophagy degradation machineries (McDonald et al., 2022; Kim et al., 2023).

The second checkpoint assesses CFTR folding through its glycosylation status. The core 14-unit oligosaccharide is processed by removal of the first two glucose units by glucosidase I and this intermediate structure is recognized by chaperone lectin calnexin (and calreticulin) which allows the progress of CFTR folding (Hammond et al., 1994). The last glucose is removed by glucosidase II, decreasing affinity for calnexin (Hammond et al., 1994). If CFTR folding is unproductive, the protein becomes a target of UDP-glycoprotein glucosyltransferase, which promotes its re-glycosylation, beginning a new round of chaperone binding, de-glycosylation and folding assessment (Hammond et al., 1994). If retained for too long in this cycle, CFTR is targeted for glycoprotein-ER associated degradation (Farinha and Amaral, 2005; Farinha and Canato, 2017).

These first two checkpoints of the ERQC system occur in the early steps of CFTR biogenesis and processing, being considered ERQC folding checkpoints. Conversely, the third and fourth checkpoints are considered ERQC trafficking checkpoints. The third checkpoint involves the recognition of abnormally exposed arginine-framed tripeptides (AFTs). AFTs are transient retention/retrieval motifs, with a Arg-X-Arg sequence, that couple ER exit to the assembly and folding of multimeric membrane or secretory proteins (Zerangue et al., 1999). AFTs only act as retrieval signal when exposed in misassembled or misfolded proteins, suggesting that the motifs are buried in assembled proteins. The masking of AFTs in native proteins is the mechanism that allows these motifs to act as retrieval signals in quality control and not as constitutive retention signals (Zerangue et al., 1999). CFTR has at least four AFTs, including Arg29-Gln30-Arg31 located at the N-terminal, Arg516-Tyr517-Arg518 and Arg553-Ala554-Arg-555 located at the nucleotide binding domain 1 (NBD1) and Arg764-Ala765-Arg766 located at the regulatory domain (RD). Exposure of these motifs has been shown to lead to retention of p.Phe508del-CFTR, while simultaneous abrogation of the motifs by substitution of arginine residues 29, 516, 555, and 766 with lysine residues, allows p.Phe508del-CFTR to evade this ERQC checkpoint without acquiring the native conformation and function at the cell surface (Chang et al., 1999; Roxo-Rosa et al., 2006; Farinha et al., 2013). Additionally, it has also been shown that the introduction of these variants alters the p.Phe508del-CFTR interactome, eliciting a possible mechanism for CFTR rescue from ER retention (Canato et al., 2018).

The fourth ERQC checkpoint involves the packing of CFTR into coat complex (COP) II coated vesicles that are destined for delivery to the ER-Golgi intermediary compartment (ERGIC). This process is dependent on the interaction between COPII proteins with specific positive export signals, with the better characterized motif for CFTR being the diacidic code Asp565-Ala566-Asp567 (DAD), which is located in NBD1 (Nishimura and Balch, 1997). This motif acts as a positive cargo signal required for Sec24-mediated COPII packaging into the vesicles (Nishimura and Balch, 1997), while its disruption has been shown to decrease both association with Sec24 and exit from the ER (Wang et al., 2004) and complete abrogation has been shown to prevent CFTR processing (Farinha et al., 2013) while also partially affecting its folding (Im et al., 2023). By successfully overcoming the ERQC CFTR is finally packed into COPII coated vesicles to traffic firstly to the ERGIC and then to the Golgi apparatus.

Native CFTR traffics through the different cisternae of the Golgi complex (from the early cis-Golgi to the media and then trans-Golgi) in COPI vesicles. During this process, CFTR’s ER-characteristic high-mannose glycan moieties undergo further processing by multiple Golgi glycosyltransferases and glycosidases that remove glycan units and add new ones characteristic of trans Golgi (fucose, neuraminic acid or sialic acid), forming complex structures (in vitro resistant to the activity of endoglycosidase H) (Amaral et al., 2016). These modifications originate a fully-glycosylated or mature form of CFTR with increased molecular weight, also known as band C CFTR (Cheng et al., 1990). After this, CFTR traffics out of the trans-Golgi for delivery at the apical PM in a process that may occur through three distinct paths: 1) directly to the membrane via transport vesicles; 2) firstly to the basolateral membrane followed by transcytosis to the apical membrane; 3) initially to apical recycling endosomes (AREs) and from there to the apical membrane. Taken together, the described processes form the conventional CFTR trafficking pathway.

In addition to this route, CFTR can traffic through possible alternative pathways from the ER to the PM, which rely on export from the ER without packaging into COPII coated vesicles or on bypassing the Golgi complex. One of the reported unconventional pathways, has been shown to occur in a cell type-specific manner, where CFTR follows a non-conventional early secretory pathway (Yoo et al., 2002). This route is insensitive to characteristic Golgi adaptors Arf1, Rab1a/Rab2 GTPases or the SNAP receptor (SNARE) component syntaxin 5. On the other hand, it depends on the late endosomal target-SNARE syntaxin 13, eliciting a possible role in CFTR maturation for recycling through a late Golgi/endosomal system (Yoo et al., 2002). These studies should however be seen with caution as they were performed in cells overexpressing CFTR. Another non-conventional secretory pathway reported is a Golgi reassembly stacking protein (GRASP)-dependent pathway, that bypasses the Golgi, and occurs only under induction of ER stress allowing the delivery of core-glycosylated CFTR, both wild type and p.Phe508del, to the PM (Gee et al., 2011). Phosphorylation of a specific site of GRASP followed by relocalization of GRASP to the ER, as well as the PDZ-based interaction of GRASP and CFTR are crucial events for this non-conventional surface trafficking pathway (Gee et al., 2011; Kim et al., 2016). More recently, another unconventional secretory pathway that also bypasses the Golgi complex has been reported for CFTR. This pathway is dependent on the activation of the IRE1α kinase-mediated signaling cascade (Park et al., 2020), which is one of the three major signaling branches of the unfolded protein response, a cellular response mechanism activated under ER stress conditions (Cox et al., 1993; Shen et al., 2001). It has been shown that IRE1α activation can promote p.Phe508del-CFTR traffic to the PM (Park et al., 2020).

After processing in the Golgi complex, mature CFTR is transported to the PM where it anchors. Evidence suggests that up to 50% of surface CFTR in airway epithelial cells exists in an immobile pool, tethered to filamentous actin which emphasizes the relevance of cytoskeleton structures in CFTR regulation (Haggie et al., 2006). CFTR anchoring and stability at the PM depends on the interaction with several proteins, among which PDZ-domain containing proteins (Figure 2A). These proteins, especially Na⁺/H⁺-exchanger regulatory factor isoform-1 (NHERF1), play an essential role of promoting interactions anchoring appropriate targets to the cytoskeleton through a multiprotein complex (Cushing et al., 2008). The CFTR-NHERF1 complex is locked in a static actin-tethered state through the interaction of NHERF1 with the actin-binding adaptor protein ezrin, preventing CFTR endocytosis. A role for NHERF1 has also been implicated in a diversity of processes, namely targeting exosome/endosome CFTR to the apical membrane of epithelial cells, promoting CFTR dimerization and enabling interactions that regulate CFTR conformation and activity (Short et al., 1998; Swiatecka-Urban et al., 2002; Haggie et al., 2006). While NHERF1 and NHERF2 stabilize CFTR at the PM, another PDZ-domain containing protein, CFTR-associated ligand (CAL), promotes CFTR endocytosis and degradation (Cheng et al., 2004), an interaction that has been assessed with the aim of identifying inhibitors that may prevent CFTR targeting to degradation (Zhao et al., 2018). Other proteins involved in CFTR stabilization at the PM link the channel to relevant signaling pathways in the cell, such cAMP signaling or regulation through phosphorylation by different kinases (reviewed in (Farinha et al., 2016)).

Regulation of CFTR trafficking by cAMP relies mainly on its interaction with the cAMP sensor exchange protein directly activated by cAMP 1 (EPAC1). It has been shown that EPAC1 and CFTR co-localize and interact mediated by NHERF1 in airway epithelial cells (Lobo et al., 2016). EPAC1 activation by cAMP promotes the EPAC1-NHERF1-CFTR interaction, that stabilizes the latter promoting an increase in its PM levels (Lobo et al., 2016; Ferreira et al., 2022), due to a decrease in endocytosis (Lobo et al., 2016). As EPAC1 is activated and linked to cAMP signaling, this interaction highlights a two-level regulation of the channel by cAMP—low concentrations of cAMP activate protein kinase A (PKA) to regulate CFTR function whereas high cAMP levels promote EPAC1-dependent increase of its PM levels (Lobo et al., 2016; Ferreira et al., 2022). More recently, several actin cytoskeleton dynamics regulators were identified in the macromolecular complexes elicited by EPAC1 activation at the PM (Santos et al., 2020)—among which the inverted formin 2 (INF2), a member of the formin family with the unique ability to accelerate actin filament depolymerization, in addition to the nucleation and elongation activities common to all formins (Chhabra and Higgs, 2006; Chhabra et al., 2009), and the F-actin-capping protein subunit alpha-2 (CAPZA2), which is a component of a heterodimeric CapZ protein that cap the fast growing barbed ends of actin filaments, terminating elongation (Caldwell et al., 1989; Barron-Casella et al., 1995). It has been reported that both these actin cytoskeleton regulators interact with CFTR and do not influence the EPAC1-NHERF1-CFTR interaction, suggesting that although not being key elements of the macromolecular complex they have an additional role in CFTR anchoring and stability at the PM (Santos et al., 2020) (Figure 2B).

cAMP-driven phosphorylation of CFTR triggers its association with 14-3-3 proteins, which contribute to facilitate CFTR trafficking along with enhancing its channel activity (Liang et al., 2012; Bozoky et al., 2013). cAMP effect on CFTR trafficking (and function) can also be modulated through inhibition of phosphodiesterases. By sustaining a localized pool of cAMP in CFTR vicinity, this allows an increase in CFTR levels at the PM and of its function. Selection inhibition of PDE4D—the most relevant phosphodiesterase in CFTR regulation (Blanchard et al., 2014)—with a mimetic peptide targeting the anchoring of PKA via the A-kinase anchoring protein PI3Kγ triggers CFTR function, possibly by also contributing to its PM stabilization (Ghigo et al., 2022) (Figure 2A).

Anterograde transport (traffic from the trans-Golgi to PM), endocytosis and recycling are the three mechanisms that act together to determine the amount of CFTR channels at the PM. These processes, particularly recycling and endocytosis, are finely regulated to control the levels of CFTR in the cell surface. Moreover, assessment of CFTR folding through the peripheral quality control mechanism also controls its total amount at the PM (Okiyoneda et al., 2010). An assortment of CFTR interacting proteins, namely Rab family small GTPases, PDZ domain-containing proteins and myosins, as well as specific trafficking motifs in the CFTR protein, participate in the regulation of trafficking turnover and retention of the protein at the PM.

CFTR endocytosis and internalization occurs in clathrin-coated vesicles (Bradbury et al., 1994; Lukacs et al., 1997), and is dependent on the recognition of specific motifs by endocytic adaptor proteins. These endocytic signals, usually 4-7 residue long sequences that are located in cytoplasmic domains of membrane proteins (Prince et al., 1999), are mainly localized in the C-terminus of CFTR (at least one tyrosine-based motif and one dileucine-based motif (Hu et al., 2001; Peter et al., 2002)). These signals are recognized by the μ2 subunit of the adaptor protein assembly polypeptide-2 (AP-2), and subsequently the β2 subunit, which binds to clathrin, forms a complex that initiates the CFTR internalization from the PM (Swiatecka-Urban et al., 2004; Madden and Swiatecka-Urban, 2012). After internalization, AP-2 and clathrin dissociate, recycling back to the PM, and the uncoated vesicles traffic through early endosomes (Swiatecka-Urban et al., 2004). At this stage of intracellular membrane trafficking, an intricate protein network is involved including the cytoskeleton, motor proteins and also protein kinases. The Rab and Rho subfamilies of Ras small GTPases emerge as key players in the regulation of protein vesicular transport between the different organelles of the secretory and endocytic pathways. Rab proteins are also responsible for regulating the interaction between motor proteins and cell membranes, enabling vesicle motility, and coordinating docking and fusion of vesicles with the correct target membranes. Many Rab proteins have been shown to regulate CFTR traffic through different mechanistic pathways (reviewed in (Farinha and Matos, 2018)). Rab5 regulates entry into early endosomes, from where CFTR can be rapidly recycled back to the PM in a mechanism that involves Rab4 (Gentzsch et al., 2004), accounting for around 50% of internalized CFTR (Cholon et al., 2010). Additionally, CFTR can be directed to recycling endosomes, from where it can follow an alternative recycling pathway to the PM dependent on Rab11 or it can be transported to late endosomes promoted by Rab7 (Gentzsch et al., 2004). It is reported that 15%–20% of internalized CFTR remains in the recycling pool reaching a steady state (Holleran et al., 2013). A return to the trans-Golgi can also occur guided by Rab9 (Gentzsch et al., 2004; Swiatecka-Urban et al., 2005). Myosins are cytoskeletal motor proteins that also participate in CFTR trafficking through interaction with Rab proteins. Myosin VI is involved in the early endocytic stages, participating in the clustering of CFTR in clathrin-coated pits and also in the formation of clathrin-coated vesicles. This role in apical membrane endocytosis is due to movement towards the F-actin minus end, oriented away from the PM, which is uncharacteristic for most myosins (Swiatecka-Urban et al., 2004). A complex of adaptors Disabled-2 (Dab-2), AP-2 and myosin VI forms at the PM promoting actin-dependent CFTR endocytosis (Swiatecka-Urban et al., 2004; Collaco et al., 2010; Fu et al., 2015). Myosin Vb also interacts with CFTR and specifically with the isoform Rab11a, depending on the recognition of the Rab-binding sites located at its tail domain (Swiatecka-Urban et al., 2007). This interaction facilitates CFTR recycling to the apical membrane of airway epithelial cells (Swiatecka-Urban et al., 2007). The other Rab11 isoform, Rab11b, also regulates CFTR recycling to the PM but in intestinal epithelial cells, eliciting a tissue-specific role for Rab11 in CFTR trafficking (Silvis et al., 2009). Altogether, recycling of internalized CFTR to the PM is considered to be the main mechanism for sustaining a functional pool of CFTR at the cell surface.

For p.Phe508del-CFTR the amount of protein at the PM is also regulated by the peripheral quality control mechanism, which links the folding status of CFTR to its internalization. This process targets misfolded proteins that reach the PM, either naturally or through pharmacological manipulation, including rescued p.Phe508del-CFTR (Okiyoneda et al., 2010). The cytoplasmic region of conformationally unstable rescued p.Phe508del-CFTR at the PM is selectively recognized by the heat shock cognate 70 kDa protein (Hsc70), in concert with other co-chaperone proteins (Okiyoneda et al., 2010). The prolonged interaction with the Hsc70/co-chaperone complex allows the recruitment of the E3 ubiquitin ligase CHIP (C terminus of Hsc70 interacting protein), leading to ubiquitination of the conformationally defective rescued p.Phe508del-CFTR at the PM. After ubiquitination, the protein is rapidly endocytosed and signaled for delivery into the degradative lysosomal compartment (Okiyoneda et al., 2010). More recently, a mechanism that allows misfolded rescued p.Phe508del-CFTR to evade the peripheral quality control has been described (Loureiro et al., 2015). This process is dependent on a conformational change of NHERF1 which is triggered by interaction with the actin-binding adaptor protein ezrin (Loureiro et al., 2015) and can be inhibited by the protease calpain (Matos et al., 2019).

CFTR stability at the PM relies also on its interaction with membrane lipids, particularly cholesterol and sphingolipids, lipid classes whose levels are affected in CFTR-deficient cells (reviewed in (Cottrill et al., 2020)). In fact, it has been shown that CFTR clusters with membrane lipids, and that the aggregation state and dynamics of CFTR at the PM are dependent on cholesterol levels. In fact, based on cholesterol abundance at the PM, CFTR molecules can exist in two different populations—a more confined and static one in high cholesterol domains and a more abundant one that is less confined and more dynamic at lower cholesterol regions (Abu-Arish et al., 2015). These domains also bring CFTR in close association with the enzyme acid sphingomyelinase and contribute to an enhancement of transepithelial secretion with a possible role in inflammation and mucosal immunity (Abu-Arish et al., 2019). More recently, it was shown that this occurs independently of scaffolding proteins (namely PDZ proteins and actin, as described above) and is driven by lipid order (Abu-Arish et al., 2022). Interestingly, these observations on the relationship between CFTR and membrane lipids in the formation of microdomains at the PM that boost a plethora of CFTR-dependent processes are aligned with recent views and more general findings on membrane dynamics—that in fact constitute an update on the classical Singer-Nicolson fluid mosaic model for PM dynamics (Kusumi et al., 2023). Based on two of the predominant components of the PM—cholesterol and actin filaments, these CFTR-centered nanoclusters play an important role not only in “securing” its PM stability and abundance but also in the regulation of other membrane channels and transporters and in the connection to signaling pathways, as it has been shown for several other PM proteins (Saha et al., 2022; Garcia-Parajo and Mayor, 2024).

Finally, phosphorylation is a major determinant in the regulation of its trafficking (reviewed elsewhere in (Farinha et al., 2016)). In most of the cases, CFTR phosphorylation triggers interaction with specific protein adaptors—as was shown recently, e.g., for the mechanism of CFTR PM regulation by spleen tyrosine kinase (SYK). Known for long to regulate CFTR PM levels (Luz et al., 2011; Mendes et al., 2011), SYK phosphorylates CFTR prompting recognition by the adaptor protein SHC1, a key regulator of MAPK pathway activity (Loureiro et al., 2020; Barros et al., 2023) (Figure 2C).

The intricate mechanisms that govern CFTR trafficking have been elucidated using a plethora of cellular models, each of which gave relevant contributions to the overall picture but that may be difficult to integrate. The challenge has increased significantly with recent advances in identification of all the cell types in the airway epithelium and their relative contribution to total CFTR expression.